are they banning tirzepatide WADA just added (mounjaro) to the 2026 Monitoring Program The FDA is considering banning

Raising NAD in heart failure: time to translate

Some regain weight after treatment is discontinued

We really need dedicated studies in people with both obesity and diabetes[to study] sufficient weight loss in that category of patients. He also emphasized that people with diabetes and obesity have two distinct diseases both of which merit optimal therapy, a gap that tirzepatide could fill

Most people face monthly costs somewhere between $25 and $969, depending on their specific insurance situation

Certain lifestyle choices may have significant impacts on the effectiveness of Wegovy for weight loss

The peptide has a uniquely high affinity for copper ions, forming a stable chelate with copper(II) that is more exchangeable than the copper bound to albumin, allowing efficient copper delivery to tissues